Overview

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to compare the efficacy of AZD6244 (ARRY-142886) with temozolomide in patients with advanced melanoma
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Treatments:
Dacarbazine
Temozolomide